Jens P. Kampmann

1.9k total citations
71 papers, 1.5k citations indexed

About

Jens P. Kampmann is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Surgery. According to data from OpenAlex, Jens P. Kampmann has authored 71 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pediatrics, Perinatology and Child Health, 14 papers in Pharmacology and 11 papers in Surgery. Recurrent topics in Jens P. Kampmann's work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Pharmaceutical Practices and Patient Outcomes (10 papers) and Pharmaceutical studies and practices (9 papers). Jens P. Kampmann is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (12 papers), Pharmaceutical Practices and Patient Outcomes (10 papers) and Pharmaceutical studies and practices (9 papers). Jens P. Kampmann collaborates with scholars based in Denmark, Sweden and Norway. Jens P. Kampmann's co-authors include Jens Hansen, Hanne Rolighed Christensen, L. Skovsted, Tage Lysbo Svendsen, Asbjørn Høegholm, Lia E. Bang, Poul Ebbe Nielsen, Michael Weis Bentzon, Niels Wiinberg and Kim Lyngby Mikkelsen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Social Science & Medicine and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jens P. Kampmann

70 papers receiving 1.4k citations

Peers

Countries citing papers authored by Jens P. Kampmann

Since Specialization

Citations

This map shows the geographic impact of Jens P. Kampmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens P. Kampmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens P. Kampmann more than expected).

Fields of papers citing papers by Jens P. Kampmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens P. Kampmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens P. Kampmann. The network helps show where Jens P. Kampmann may publish in the future.

Co-authorship network of co-authors of Jens P. Kampmann

This figure shows the co-authorship network connecting the top 25 collaborators of Jens P. Kampmann. A scholar is included among the top collaborators of Jens P. Kampmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens P. Kampmann. Jens P. Kampmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	[Self-medication with cannabidiol oil in a patient with primary lateral sclerosis]. 2017 ·PubMed ·Merete Karlsborg, (unknown), (unknown), Jens P. Kampmann	1
2	Quality assessment of structure and language elements of written responses given by seven Scandinavian drug information centres 2017 ·European Journal of Clinical Pharmacology ·(unknown), Olav Spigset, Jens P. Kampmann, Per Damkier, Hanne Rolighed Christensen, Ylva Böttiger, Jan Schjøtt	6
3	Factors associated with time consumption when answering drug-related queries to Scandinavian drug information centres: a multi-centre study 2014 ·European Journal of Clinical Pharmacology ·(unknown), Olav Spigset, Ylva Böttiger, Hanne Rolighed Christensen, Jens P. Kampmann, Per Damkier, Stian Lydersen, Jan Schjøtt	11
4	Promotional methods used by representatives of drug companies: A prospective survey in general practice 2007 ·Scandinavian Journal of Primary Health Care ·Jesper Schramm, Morten Andersen, Kirstin Vach, Jakob Kragstrup, Jens P. Kampmann, Jens Søndergaard	20
5	The effects of introducing a clinical pharmacist on orthopaedic wards in Denmark 2007 ·Pharmacy World & Science ·Thomas Buck, (unknown), Ivan Brandslund, Jens P. Kampmann	25
6	Creating knowledge about adverse drug reactions: A critical analysis of the Danish reporting system from 1968 to 2005 2007 ·Social Science & Medicine ·Lise Aagaard, (unknown), (unknown), Jens P. Kampmann, Ebba Holme Hansen	16
7	General practitioners prefer prescribing indicators based on detailed information on individual patients: a Delphi study 2005 ·European Journal of Clinical Pharmacology ·(unknown), Jens Søndergaard, Jens P. Kampmann, Morten Andersen	22
8	Utilisation of antibiotics in young children: opposite relationships to adult educational levels in Danish and Swedish counties 2003 ·European Journal of Clinical Pharmacology ·Eva Melander, (unknown), (unknown), Juan Merlo, (unknown), Jens P. Kampmann, Thor Lithman, Ebba Holme Hansen, Arne Melander	17
9	Blood Pressure in Acute Stroke 2002 ·Cerebrovascular Diseases ·Henrik Jørgensen, Hirofumi Nakayama, (unknown), Hans Otto Raaschou, Jens P. Kampmann, Tom Skyhøj Olsen	55
10	Bioavailability and Pharmacokinetics of Isradipine after Oral and Intravenous Administration: Half-Life Shorter than Expected? 2000 ·Pharmacology & Toxicology ·(unknown), Kristian Antonsen, Knud Simonsen, A. L. LINDEKÆR, Jan Bonde, Helle R. Angelo, Jens P. Kampmann	20
11	Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease 1999 ·Respiratory Medicine ·Thomas Senderovitz, Jørgen Vestbo, Jacob Frandsen, Niels Maltbæk, Mette Nørgaard, (unknown), Jens P. Kampmann, (unknown)	39
12	Dose-finding study of oral metopimazine 1997 ·Supportive Care in Cancer ·Jørn Herrstedt, (unknown), Helle R. Angelo, Jens P. Kampmann, Mogens Hansen	10
13	24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender* 1995 ·American Journal of Hypertension ·Niels Wiinberg, Asbjørn Høegholm, Hanne Rolighed Christensen, Lia E. Bang, Kim Lyngby Mikkelsen, Poul Ebbe Nielsen, Tage Lysbo Svendsen, Jens P. Kampmann, (unknown), Michael Weis Bentzon	328
14	Cyclosporin Pharmacokinetics after Intravenous and Oral Administration in Patients with Crohn's Disease 1992 ·Scandinavian Journal of Gastroenterology ·Jørn Brynskov, L Freund, Mauro Campanini, Jens P. Kampmann	24
15	Codeine in Analgesic Doses Does not Depress Respiration in Patients with Severe Chronic Obstructive Lung Disease 1990 ·Pharmacology & Toxicology ·Lars Kristian Munck, (unknown), (unknown), Ulla Lei Larsen, Poul Erik Branebjerg, Jens P. Kampmann	8
16	Influence of rifampicin on thyroid gland volume, thyroid hormones, and antipyrine metabolism 1989 ·European Journal of Endocrinology ·Hanne Rolighed Christensen, (unknown), (unknown), Bo Mølholm Hansen, Martin Døssing, Jens P. Kampmann, Jens M. Hansen	10
17	Disposition Kinetics of Disopyramide in Human Healthy Volunteers Described by an Open Three Compartment Model 1989 ·Pharmacology & Toxicology ·Jan Bonde, Niels Melchior Jensen, L. E. Pedersen, Helle R. Angelo, (unknown), J. Trap‐Jensen, Jens P. Kampmann	2
18	Elimination Kinetics and Urinary Excretion of Disopyramide in Human Healthy Volunteers 1988 ·Pharmacology & Toxicology ·Jan Bonde, Niels Melchior Jensen, L. E. Pedersen, Niels Graudal, Helle R. Angelo, Jens P. Kampmann	2
19	Clinical Pharmacokinetics and Potentially Important Drug Interactions of Sulphinpyrazone 1982 ·Clinical Pharmacokinetics ·A. K. Pedersen, (unknown), Jens P. Kampmann, J. Mølholm Hansen	16
20	[Adverse drug reactions in a surgical department]. 1978 ·PubMed ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jens P. Kampmann, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact